Jiaqi Zhang
Shenzhen Key Laboratory Of Pathogen And Immunity
Shenzhen, China
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant Klebsiella pneumoniae.
Journal: Microbiology spectrum
Published: December 07, 2023
The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody.
Journal: Frontiers in cellular and infection microbiology
Published: April 12, 2023
Case report: Clinical and virological characteristics of aseptic meningitis caused by a recombinant echovirus 18 in an immunocompetent adult.
Journal: Frontiers in medicine
Published: November 10, 2022
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China.
Journal: The Lancet. Microbe
Published: July 07, 2022
Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2.
Journal: Signal transduction and targeted therapy
Published: June 19, 2022
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees.
Journal: The Journal of infection
Published: December 30, 2021
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects.
Journal: Frontiers in cellular and infection microbiology
Published: October 08, 2021
T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients.
Journal: Frontiers in immunology
Published: September 02, 2021
Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients.
Journal: Frontiers in immunology
Published: May 28, 2021
Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.
Journal: Frontiers in immunology
Published: February 01, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026